| Trial ID: | L6661 |
| Source ID: | NCT00506961
|
| Associated Drug: |
Rosuvastatin
|
| Title: |
Evaluate the Efficacy and Safety of Rosuvastatin Versus Simvastatin in Type 2 Diabetic Patients With Dyslipidemia
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus|Dyslipidemia
|
| Interventions: |
DRUG: Rosuvastatin|DRUG: Simvastatin
|
| Outcome Measures: |
Primary: The percentage of patients achieving the combined treatment goal of LDL-C < 100mg/dl and non-HDL-C < 130 mg/dl at week 12 with rosuvastatin treatment compared with simvastatin treatment, 12 weeks | Secondary: Achieving the combined treatment goal of LDL-C (<100 mg/dL) and non-HDL-C (130 mg/dL) at week 4;, 4 weeks|Percentage of patients achieving the LDL-C goal of <100 mg/dL at week 4 and week 12;, 12 weeks|Percentage of patients achieving the LDL-C goal of <70 mg/dL at Week;The mean percent change from baseline in lipid profile at week 4 and week 12;, 12 weeks
|
| Sponsor/Collaborators: |
Sponsor: Taipei Veterans General Hospital, Taiwan
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
90
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH
|
| Start Date: |
2006-06
|
| Completion Date: |
2007-07
|
| Results First Posted: |
|
| Last Update Posted: |
2011-12-06
|
| Locations: |
Taichung Veterans General Hospital, Taichung, Taiwan|Taipei Veterans General Hospital, Taipei, Taiwan
|
| URL: |
https://clinicaltrials.gov/show/NCT00506961
|
